Alfresa HoldingsALFRY 75 EBIT per Share is $2.23 as of Mar. 2026. GuruFocus rates ALFRY with a GF Score™ of 75/100 and a GF Value™ of $16.25 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 105 Medical Distribution companies, Alfresa Holdings ranks better than 63.81% on this metric.
Alfresa Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was $0.51.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.23.
During the past 12 months, the average EBIT per Share Growth Rate of Alfresa Holdings was -3.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 10.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 10.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -0.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Alfresa Holdings's EBIT per Share or its related term are showing as below:
ALFRY'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -33.4 Med: 5.4 Max: 51
Current: 10.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Alfresa Holdings was 51.00% per year. The lowest was -33.40% per year. And the median was 5.40% per year.
ALFRY's 3-Year EBIT Growth Rate is ranked better than 63.81% of 105
companies
in the Medical Distribution industry
Industry Median: 4.2
vs ALFRY: 10.10
Alfresa Holdings (OTCPK:ALFRY) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Alfresa Holdings EBIT per Share Related Terms
Alfresa Holdings EBIT per Share Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alfresa Holdings (ALFRY) has a EBIT per Share of $2.23 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Alfresa Holdings and its competitors. According to the industry distribution chart, Alfresa Holdings ranks #38 out of 105 companies in the Medical Distribution industry, placing it in the top 36.2%.
Is Alfresa Holdings' EBIT per Share too high?
Alfresa Holdings' current EBIT per Share is $2.23. The Medical Distribution industry median EBIT per Share is 4.20. Alfresa Holdings' value of $2.23 is 46.9% below this industry median. Based on the distribution chart, Alfresa Holdings ranks #38 out of 105 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Alfresa Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' EBIT per Share compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #38 out of 105 companies for EBIT per Share. This puts Alfresa Holdings in the upper half of its industry. The industry median EBIT per Share is 4.20. Alfresa Holdings' value of $2.23 is 46.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current EBIT per Share of $2.23 is 46.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current EBIT per Share is $2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.25, compared to a current price of $13.80 — trading 15.1% below its estimated fair value. The current EBIT per Share is $2.23 and 46.9% below the Medical Distribution industry median of 4.20. Alfresa Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current EBIT per Share is $2.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (ALFRY) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of $13.80 is trading 15.1% below its estimated GF Value™ of $16.25.
GuruFocus considers Alfresa Holdings to be Modestly Undervalued.
Key valuation signals for ALFRY:
EBIT per Share: $2.23
GF Value™: $16.25 vs. price of $13.80 (15.1% below fair value)
Industry Position: 46.9% below the Medical Distribution median (#38 of 105)
No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
75GF Score
Get the complete analysis for ALFRY
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALFRY has been successfully added to your 
